![Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4 - ScienceDirect Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0045206821006155-gr1.jpg)
Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4 - ScienceDirect
![Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate | Journal of Medicinal Chemistry Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c01747/asset/images/large/jm1c01747_0021.jpeg)
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate | Journal of Medicinal Chemistry
Design, Synthesis, and Biological Evaluation of 2-Formyl Tetrahydronaphthyridine Urea Derivatives as New Selective Covalently Reversible FGFR4 Inhibitors | Journal of Medicinal Chemistry
Synthesis of 2-pyridylthiophosphinic acids and 2-pyridylthiophosphonate monoesters via nucleophilic aromatic substitution
![Design, Synthesis, and Biological Evaluation of 2-Formyl Tetrahydronaphthyridine Urea Derivatives as New Selective Covalently Reversible FGFR4 Inhibitors | Journal of Medicinal Chemistry Design, Synthesis, and Biological Evaluation of 2-Formyl Tetrahydronaphthyridine Urea Derivatives as New Selective Covalently Reversible FGFR4 Inhibitors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c01816/asset/images/medium/jm1c01816_0015.gif)